1,027 material Form 8-K filings that 835 companies we cover made with the SEC in February 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Louisiana-Pacific reported fourth-quarter and full-year 2024 results in a press release dated February 19, 2025, filed with the SEC as Exhibit 99.1. Q4 net sales rose 3% to $681 million and full-year net income reached $420 million, but the company guided 2025 consolidated Adjusted EBITDA to $615 million to $635 million, below the $688 million reported for 2024.
Q4 2024 net sales rose 3% to $681 million; net income was $63 million ($0.89 per diluted share) versus $0.81 a year earlier.
Q4 Adjusted EBITDA fell $5 million to $125 million; full-year 2024 net income was $420 million ($5.89 per diluted share), up $243 million.
2025 consolidated Adjusted EBITDA guidance is $615 million to $635 million for the full year and $130 million to $150 million for Q1 2025.
Quarterly dividend for Q1 2025 was raised to $0.28 per share from $0.26.
On February 13, 2025, MPT's operating partnership closed $1.5 billion of 8.500% notes due 2032 and €1.0 billion of 7.000% notes due 2032, and the company amended its revolving credit and term loan agreement. The notes are secured by first-priority liens on equity of subsidiaries owning or ground leasing 169 properties, and the amendment extends the revolving facility's maturity to June 30, 2027 while removing several financial covenants and resetting the interest rate to SOFR plus 2.25%. The filing shows new secured debt ranking alongside the credit facility, which may affect how much collateral is available to unsecured creditors and shareholders.
$1.5 billion of 8.500% Senior Secured Notes due February 15, 2032 and €1.0 billion of 7.000% Senior Secured Notes due 2032 were issued under an indenture dated February 13, 2025.
Notes are secured by first-priority liens on equity of subsidiaries that own or ground lease 169 properties with 20 operators in the United States, United Kingdom and Germany.
Amendment No. 3 extends the revolving credit facility maturity to June 30, 2027, resets interest to SOFR plus 2.25% and sets a maximum secured leverage ratio of 40%.
Before February 15, 2028, up to 40% of each note series may be redeemed at 108.500% (dollar notes) or 107.000% (euro notes) using equity offering proceeds.
CVR Energy reported fourth-quarter 2024 net income attributable to stockholders of $28 million, or 28 cents per diluted share, down from $91 million, or 91 cents, a year earlier. Adjusted results moved to a loss of 13 cents per share from adjusted earnings of 65 cents, and full-year net income attributable fell to $7 million, or 6 cents per share, from $769 million, or $7.65. The company attributed the refining decline mainly to lower crack spreads and, to a lesser degree, lower throughput.
Fourth-quarter 2024 net sales were $1.947 billion, compared with $2.202 billion in the fourth quarter of 2023.
Full-year 2024 net income attributable to CVR Energy stockholders was $7 million, or 6 cents per share, versus $769 million, or $7.65 per share, in 2023.
Petroleum Segment adjusted EBITDA was $9 million in the fourth quarter of 2024, compared with $152 million a year earlier; adjusted refining margin was $6.45 per barrel versus $12.91.
The company raised $408 million in the fourth quarter of 2024 through a Term Loan and the sale of its 50% interest in Midway Pipeline, and ended 2024 with $987 million in cash.
Sonoco reported a fourth-quarter 2024 GAAP net loss attributable to Sonoco of $43 million, or $(0.44) per diluted share, compared with net income of $81 million a year earlier. Adjusted diluted EPS was $1.00 versus $1.02, and full-year 2024 net sales fell 3% to $5.3 billion. The company guided 2025 adjusted EPS to $6.00 to $6.20, which it says reflects growth from the Eviosys acquisition completed December 4, 2024.
Q4 2024 net sales were $1.4 billion, up 2%, while GAAP operating profit fell to $56 million from $103 million
Full-year 2024 GAAP diluted EPS was $1.65 versus $4.80; adjusted diluted EPS was $4.89 versus $5.26
2025 guidance: adjusted EPS of $6.00 to $6.20, operating cash flow of $750 million to $850 million, and adjusted EBITDA of $1.3 billion to $1.4 billion
Agreement to sell the TFP business to TOPPAN Holdings, Inc. for approximately $1.8 billion
Loews Corporation's Compensation Committee set the compensation for Benjamin J. Tisch, who was appointed President and Chief Executive Officer effective January 1, 2025, and approved special stock appreciation right (SAR) grants to him, Alexander H. Tisch and CFO Jane J. Wang. The SARs only deliver value if Loews stock rises to $100, $150 or $200 per share, and the filing describes them as not part of regular annual pay, so shareholders may see added incentive tied to share price gains.
Benjamin J. Tisch base salary $1,000,000; 2025 target cash incentive $2,600,000; 2025 target PRSU award of 10,690 units with grant date fair value of $900,000
Special SAR grants on February 17, 2025 total 100,000, 150,000 and 200,000 SARs for Benjamin and Alexander Tisch at $100, $150 and $200 exercise prices
Grant date fair value of SAR awards: $4,093,500 each for Benjamin and Alexander Tisch; $3,070,125 for Jane J. Wang
SARs have a 10-year term and become exercisable seven years after grant
Comstock Resources reported fourth-quarter 2024 results with a GAAP net loss of $55.3 million, compared with net income of $108.4 million a year earlier. The loss reflects a $126.9 million unrealized hedging loss, and adjusted net income rose to $46.3 million, or $0.16 per share, while revenue fell, and the company reported that proved reserves fell to 3.8 Tcfe from 4.9 Tcfe, which shareholders should weigh alongside a planned increase in 2025 drilling spending.
Q4 2024 net loss was $55.3 million, or $0.19 per share, versus net income of $108.4 million, or $0.39 per share, in Q4 2023.
Q4 2024 adjusted net income was $46.3 million, or $0.16 per share, versus $27.9 million, or $0.10 per share, in Q4 2023.
Q4 2024 total revenues were $366.5 million, down from $410.6 million; production was 124.2 Bcfe versus 140.6 Bcfe.
Proved reserves at December 31, 2024 were 3.8 Tcfe, down from 4.9 Tcfe, with 2025 development spending planned at $1.0 billion to $1.1 billion.
SiriusPoint reported a fourth quarter 2024 net loss of $21.3 million, or $0.13 per diluted share, which the company attributed mainly to three one-off items tied to its repositioning. Core combined ratio improved to 90.2% from 93.4% a year earlier, and full-year 2024 net income available to common shareholders was $183.9 million, or $1.04 per diluted share.
Q4 2024 net loss attributable to common shareholders of $21.3 million, or $0.13 per diluted share, driven by the CM Bermuda repurchase, closure of the Enstar LPT transaction, and a write-down of a single MGA investment
Q4 2024 Core combined ratio of 90.2%, versus 93.4% in Q4 2023; Core income of $66.7 million, versus $46.3 million
Full-year 2024 underlying net income of $304 million, up 14% from the prior year; full-year Core combined ratio of 91.0%, versus 89.1% in 2023
Book value per diluted common share ex. AOCI of $14.64 at December 31, 2024, up from $13.33 a year earlier
JBG SMITH reported a full-year 2024 net loss of $143.5 million, or $1.65 per diluted share, up from a $80.0 million loss, or $0.78 per share, in 2023. Core FFO fell to $73.9 million ($0.83 per diluted share) from $154.1 million ($1.46) a year earlier, and the company expects earnings to keep declining during the first half of 2025.
Full-year 2024 net loss was $143.5 million ($1.65 per diluted share) versus $80.0 million ($0.78) in 2023.
Fourth-quarter Core FFO was $11.6 million ($0.14 per diluted share), down from $36.1 million ($0.38) a year earlier.
The company expects continued decreases in earnings and higher Net Debt to Annualized Adjusted EBITDA during the first half of 2025.
Share repurchase capacity is about $840 million, and the company repurchased $170.7 million of shares in 2024.
Devon Energy reported fourth-quarter 2024 net earnings of $639 million, or $0.98 per diluted share, and core earnings of $756 million, or $1.16 per share. The company raised its quarterly dividend 9 percent to $0.24 per share and lowered its 2025 capital program by about $200 million while raising its production forecast, which matters to shareholders because it adds to capital returned and reflects a higher expected output for less capital.
Q4 2024 net earnings were $639 million, up from $812 million in Q3 2024 but down from $1,152 million in Q4 2023.
Q4 2024 free cash flow was $738 million, and the company returned $444 million to shareholders through dividends and buybacks.
2025 production outlook raised 2 percent to 805,000 to 825,000 Boe per day; capital program of $3.8 to $4.0 billion, a 5 percent or $200 million decline.
Quarterly dividend raised 9 percent to $0.24 per share, payable Mar. 31, 2025, to holders of record on Mar. 14, 2025.
Penumbra reported fourth-quarter and full-year 2024 results, with revenue up 10.8% in the quarter and 12.9% for the year. Net income fell sharply, to $14.0 million for the year from $91.0 million in 2023, largely due to a $76.9 million impairment charge tied to its Immersive Healthcare business. The company projected 2025 revenue of $1,340.0 million to $1,360.0 million, growth of 12% to 14%.
Q4 2024 revenue was $315.5 million, up 10.8% from $284.7 million; Q4 net income was $33.7 million versus $54.2 million a year earlier.
Full-year 2024 revenue was $1,194.6 million, up 12.9%, but income from operations fell to $9.3 million from $73.6 million.
The 2024 results include a $76.9 million impairment charge and a $5.8 million Italian government payback provision.
For 2025, the company projects total revenue of $1,340.0 million to $1,360.0 million and operating margin of 13% to 14%.
MasterBrand reported fourth-quarter 2024 net sales of $667.7 million, down 1% from a year earlier, and net income of $14.0 million, down 61%. The company also introduced 2025 guidance calling for adjusted EBITDA of $380 million to $410 million and adjusted diluted EPS of $1.40 to $1.57, while noting that tariff impacts beyond those in effect on the release date are not included.
Q4 2024 diluted EPS was $0.11 versus $0.28 in Q4 2023; adjusted diluted EPS was $0.21 versus $0.35
Full-year 2024 net sales were $2.7 billion, down 1%; net income was $125.9 million, down 31%
2025 outlook: adjusted EBITDA of $380 million to $410 million; adjusted diluted EPS of $1.40 to $1.57 (full-year 2024 adjusted diluted EPS was $1.37)
No shares were repurchased in Q4 2024; the company repurchased about 371 thousand shares for about $6.5 million over the full year
Sirius XM Holdings said it hired Richard N. Baer, former chief legal officer of Airbnb, as Executive Vice President, General Counsel and Secretary, effective March 3, 2025. He succeeds Patrick Donnelly, who is retiring, and the filing sets out a three-year employment agreement with a $1,000,000 base salary and a 150% target bonus. For shareholders, this is a senior officer change with compensation terms tied in part to three-year free cash flow and relative total shareholder return.
Baer's employment term runs March 3, 2025 to March 4, 2028, renewing automatically each March 4 unless either party gives notice.
Base salary is $1,000,000, with a target annual bonus of 150% of base salary and a one-time $500,000 sign-on bonus.
Equity grants total $5,000,000 in RSUs: $1,500,000 time-based, $2,000,000 time-based and $1,500,000 performance-based tied to three-year free cash flow and relative TSR for 2025 to 2027.
Baer succeeds Patrick Donnelly, who is retiring after nearly twenty-seven years with the company.
Otter Tail reported 2024 diluted EPS of $7.17, up from $7.00 in 2023, on net income of $301.7 million, while full-year operating revenues fell to $1.33 billion from $1.35 billion. The company's 2025 diluted EPS guidance of $5.68 to $6.08 is below 2024 actual results, with declines expected in the Plastics and Manufacturing segments, which matters to shareholders for near-term earnings expectations.
2024 diluted EPS was $7.17 versus $7.00 in 2023; fourth-quarter diluted EPS was $1.30 versus $1.37.
2025 diluted EPS guidance is $5.68 to $6.08, with Plastics expected to decline 29% and Manufacturing expected to decline 27%.
Electric segment earnings are expected to rise 7% in 2025, based on an average rate base increase of 12%.
Long-term EPS growth target was raised to 6 to 8% from 5 to 7%; five-year capital spending plan totals $1.4 billion for the Electric segment.
Genuine Parts reported fourth-quarter and full-year 2024 results on February 18, 2025. Sales rose in both periods, but diluted earnings per share fell sharply, weighed by restructuring costs and a $62 million inventory write-down, and the company issued 2025 guidance and raised its quarterly dividend 3%.
Q4 2024 GAAP diluted EPS was $0.96, versus $2.26 a year earlier; adjusted diluted EPS was $1.61 versus $2.26 in the prior-year quarter.
Full-year 2024 sales were $23.5 billion, up 1.7%; GAAP diluted EPS was $6.47 versus $9.33, and adjusted diluted EPS was $8.16, down 12.5%.
2025 guidance calls for adjusted diluted EPS of $7.75 to $8.25 and total sales growth of 2% to 4%; GAAP EPS guidance excludes a pension settlement charge expected in late 2025 or early 2026.
Quarterly dividend raised 3% to $1.03 per share, payable April 2, 2025 to shareholders of record March 7, 2025.
Tennant reported record full-year 2024 net sales of $1.29 billion, up 3.5%, but net income fell 23.6% to $83.7 million and diluted EPS fell 24.9% to $4.38. The company's 2025 guidance projects net sales of $1.21 billion to $1.25 billion and an organic sales decline of 1% to 4%, which shareholders will weigh against the weaker profit trend.
Full-year 2024 net sales rose 3.5% to $1,286.7 million; diluted EPS fell to $4.38 from $5.83.
Fourth-quarter net income was $6.6 million, down 78.7%, and included $10.3 million of legal contingency costs.
2025 guidance: net sales of $1,210 million to $1,250 million, organic net sales decline of 1% to 4%, and diluted EPS of $3.80 to $4.30.
Full-year adjusted EBITDA rose 8.2% to $208.8 million, with a 16.2% margin.
Watsco reported fourth-quarter 2024 sales of $1.75 billion, up 9%, and diluted EPS of $2.37, up from $2.06 a year earlier. For full-year 2024, sales rose 5% to a record $7.62 billion, but diluted EPS fell to $13.30 from $13.67. The board also raised the annual dividend 11% to $12.00 per share, effective with the April 2025 payment.
Q4 net income attributable to Watsco rose 17% to $97 million; Q4 diluted EPS was $2.37 versus $2.06.
Full-year net income attributable to Watsco was $536 million, flat with 2023; full-year diluted EPS was $13.30 versus $13.67.
Full-year operating cash flow rose 38% to a record $773 million.
Annual dividend increased to $12.00 per share from the April 2025 payment; the company has paid dividends for 51 consecutive years.
Blackbaud reported unaudited fourth-quarter and full-year 2024 results, with a GAAP net loss driven by $405.4 million in EVERFI impairment and disposition charges. Revenue grew, and full-year non-GAAP diluted EPS rose to $4.07, but the company also issued 2025 guidance with GAAP revenue of $1.115 billion to $1.125 billion, below its 2024 GAAP revenue of $1.155 billion.
Q4 2024 GAAP total revenue was $302.2 million, up 2.4%; Q4 GAAP net loss was $330.8 million, or $6.74 per diluted share.
Full-year 2024 GAAP total revenue was $1.2 billion (exact $1.155 billion), up 4.5%; full-year GAAP net loss was $283.2 million, or $5.60 per share.
Full-year 2024 non-GAAP diluted EPS was $4.07, up $0.09; 2025 guidance calls for non-GAAP EPS of $4.16 to $4.35.
The company plans to buy back 3% to 5% of its outstanding shares in 2025; about $645 million remained under its repurchase program as of December 31, 2024.
Asbury Automotive Group agreed on February 14, 2025 to acquire substantially all assets of The Herb Chambers Companies for about $1.34 billion, covering 33 dealerships, 52 franchises and three collision centers in Massachusetts and Rhode Island. The company said the deal is expected to close late in the second quarter of 2025, subject to manufacturer approvals, regulatory clearances and other customary conditions, and that it will be funded with credit facility capacity, mortgage proceeds and cash. The size of the purchase is large relative to the deals described in the filing, and closing is not assured until those conditions are met.
Purchase price is about $1.34 billion, including $750 million for goodwill and about $590 million for real estate and improvements
The acquired businesses include 33 dealerships, 52 franchises and three collision centers; the seller retains the Mercedes-Benz of Boston dealership
Closing requires manufacturer approvals and Hart-Scott-Rodino waiting period expiration, and is expected late in the second quarter of 2025
Asbury will deliver $10 million in earnest money; the seller may owe a $100 million termination fee in some circumstances
Fluor reported fourth quarter and full year 2024 results on February 18, 2025. Revenue rose to $16.3 billion and GAAP net income attributable to Fluor reached $2.1 billion, or $12.30 per diluted share, driven by a $2.2 billion NuScale-related equity method gain, while adjusted EPS fell to $2.32 from $2.73 and new awards and backlog declined. Fluor set 2025 adjusted EBITDA guidance of $575 million to $675 million and adjusted EPS guidance of $2.25 to $2.75.
Full year 2024 revenue was $16.3 billion, up from $15.5 billion in 2023; adjusted EBITDA was $530 million, down from $613 million.
Net income reflected $2,221 million for deconsolidation and remeasurement of the NuScale investment, partly offset by a $116 million jury-verdict provision at a joint venture.
New awards were $15.1 billion versus $19.5 billion, and ending backlog was $28.5 billion versus $29.4 billion.
2025 guidance: adjusted EBITDA of $575 million to $675 million and adjusted EPS of $2.25 to $2.75 per share; Q4 share repurchases were $125 million, with $300 million planned for 2025.
Constellation Energy reported fourth-quarter 2024 GAAP net income of $2.71 per share, up from a loss of $0.11 a year earlier, and adjusted operating earnings of $2.44 per share, up from $1.74. Full-year 2024 adjusted operating earnings of $8.67 per share exceeded the top of the company's twice-revised guidance range of $8.00-$8.40, while quarterly operating revenues fell to $5.4 billion from $5.8 billion, and the company affirmed its 2025 adjusted operating earnings guidance of $8.90-$9.60 per share.
Q4 2024 GAAP EPS was $2.71 (diluted) versus ($0.11) in Q4 2023; adjusted operating EPS was $2.44 versus $1.74.
Q4 2024 operating revenues were $5,382 million versus $5,796 million in Q4 2023.
Full-year 2024 adjusted operating EPS was $8.67, above the $8.00-$8.40 guidance range; 2025 guidance of $8.90-$9.60 was affirmed.
The company entered a definitive agreement to acquire Calpine Corporation for 50 million shares plus $4.5 billion in cash, and bought back about $1 billion of stock in 2024.
Gilead Sciences' time-limited exclusive option to casdatifan expired without exercise, so Gilead has no future rights to the program and Arcus retains full global development and commercial rights, subject to Taiho's option for Japan and certain other Asian countries (excluding China). Arcus also reported preliminary cash, cash equivalents and marketable securities of approximately $992 million as of December 31, 2024, which remains unaudited and subject to closing procedures.
Gilead's casdatifan option expired without exercise, as announced February 18, 2025; Gilead has no future rights to casdatifan.
Taiho Pharmaceutical's option right covers its territory, limited to Japan and certain other Asian countries (excluding China).
Preliminary cash, cash equivalents and marketable securities were approximately $992 million as of December 31, 2024, unaudited and may change.
ARC-20 data reported February 15, 2025 (data cut-off January 3, 2025): confirmed ORR of 33% (9) in the 100mg QD cohort of 27 patients.
UFP Industries reported fourth-quarter 2024 net sales of $1.46 billion, down 4 percent, and net earnings attributable to controlling interest of $68.0 million, down 34 percent. Diluted earnings per share were $1.12 versus $1.62 a year earlier, including impairment and severance charges of about $0.11 per share. Management expects softer demand and a competitive pricing environment to continue through the first half of 2025.
Q4 2024 net sales of $1.46 billion fell 4 percent, driven by a 4 percent decrease in selling prices.
Q4 net earnings attributable to controlling interest were $68.0 million, down 34 percent; diluted EPS was $1.12 versus $1.62.
Fiscal 2024 net sales were $6.7 billion, down 8 percent, with diluted EPS of $6.77 versus $8.07 in fiscal 2023.
Management expects softer demand and competitive pricing through the first half of 2025; the filing gives no numeric guidance.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.